Vyera Pharmaceuticals

Vyera Pharmaceuticals focuses on developing therapies specifically targeting patients with severe and neglected diseases where significant unmet needs exist. Toxoplasmosis is one of the areas of focus for Vyera Pharmaceuticals. Vyera's discovery program is seeking new drug candidates with the goal of creating a treatment that is more effective and better tolerated than current options. Several compounds are currently being tested. Vyera supports programs to assist patients who may have difficulty affording treatment and offers discounts to organizations providing care to underserved patients.